BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 476569)

  • 21. Necrolytic migratory erythema without glucagonoma versus canine superficial necrolytic dermatitis: is hepatic impairment a clue to pathogenesis?
    Kasper CS; McMurry K
    J Am Acad Dermatol; 1991 Sep; 25(3):534-41. PubMed ID: 1655838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Necrolytic Migratory Erythema: A Forgotten Paraneoplastic Condition.
    Tremblay C; Marcil I
    J Cutan Med Surg; 2017; 21(6):559-561. PubMed ID: 28662584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Necrolytic cutaneous erythema and pancreatic tumour: the glucagonoma].
    Drematcheff S; Champetier de Ribes TL; Marty C; Sans N; Railhac JJ
    J Radiol; 2004 Mar; 85(3):329-31. PubMed ID: 15192527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Images in clinical medicine. Necrolytic migratory erythema.
    McGevna L; Tavakkol Z
    N Engl J Med; 2010 Jan; 362(1):e1. PubMed ID: 20054043
    [No Abstract]   [Full Text] [Related]  

  • 25. Necrolytic migratory erythema: the outermost marker for glucagonoma syndrome.
    Gantcheva ML; Broshtilova VK; Lalova AI
    Arch Dermatol; 2007 Sep; 143(9):1221-2. PubMed ID: 17875900
    [No Abstract]   [Full Text] [Related]  

  • 26. [Necrolytic migratory erythema in glucagonoma syndrome (author's transl)].
    Kitoh M; Ohyama K; Shigeo ; Arao AT
    Nihon Hifuka Gakkai Zasshi; 1981 Apr; 91(5):559-68. PubMed ID: 6270429
    [No Abstract]   [Full Text] [Related]  

  • 27. Migratory necrolytic erythema and glucagonoma.
    Echenique-Elizondo M; Elorza JL; De Delas JS
    Surgery; 2003 Apr; 133(4):449-50. PubMed ID: 12717367
    [No Abstract]   [Full Text] [Related]  

  • 28. Necrolytic migratory erythema: dyskeratotic dermatitis, a clue to early diagnosis.
    Hunt SJ; Narus VT; Abell E
    J Am Acad Dermatol; 1991 Mar; 24(3):473-7. PubMed ID: 2061449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of somatostatin in necrolytic migratory erythema of glucagonoma.
    Elsborg L; Glenthøj A
    Acta Med Scand; 1985; 218(2):245-9. PubMed ID: 2865872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The question of surgical therapy for necrolytic migratory erythema, a cutaneous disease].
    Siegel R; Linse R; Rau B
    Chirurg; 2006 Jun; 77(6):535-8. PubMed ID: 16362349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Necrolytic migratory erythema and pancreatic glucagonoma.
    Rodríguez G; Vargas E; Abaúnza C; Cáceres S
    Biomedica; 2016 Jun; 36(2):176-81. PubMed ID: 27622478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Glucagonoma revealed by necrolytic migratory erythema].
    Bonaventure C; Merle P; Grezard P; Ruiz JM; Chevallier M; Scoazec JY; Trepo C
    Gastroenterol Clin Biol; 2003 Feb; 27(2):230-2. PubMed ID: 12658134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dermatitis, glossitis, stomatitis, cheilitis, anemia and weight loss: a classic presentation of pancreatic glucagonoma.
    Povoski SP; Zaman SA; Ducatman BS; McFadden DW
    W V Med J; 2002; 98(1):12-4. PubMed ID: 11941895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful treatment of glucagonoma-related necrolytic migratory erythema with dacarbazine.
    van der Loos TL; Lambrecht ER; Lambers JC
    J Am Acad Dermatol; 1987 Feb; 16(2 Pt 2):468-72. PubMed ID: 3029193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Necrolytic migratory erythema as the first manifestation of pancreatic neuroendocrine tumor.
    Wu SL; Bai JG; Xu J; Ma QY; Wu Z
    World J Surg Oncol; 2014 Jul; 12():220. PubMed ID: 25029913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucagon cell adenomatosis: a new entity associated with necrolytic migratory erythema and glucagonoma syndrome.
    Otto AI; Marschalko M; Zalatnai A; Toth M; Kovacs J; Harsing J; Tulassay Z; Karpati S
    J Am Acad Dermatol; 2011 Aug; 65(2):458-459. PubMed ID: 21763589
    [No Abstract]   [Full Text] [Related]  

  • 37. Putting the pieces together: necrolytic migratory erythema and the glucagonoma syndrome.
    Halvorson SA; Gilbert E; Hopkins RS; Liu H; Lopez C; Chu M; Martin M; Sheppard B
    J Gen Intern Med; 2013 Nov; 28(11):1525-9. PubMed ID: 23681843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Necrolytic migratory erythema: first symptom of a glucagonoma. A case report.
    Du Jardin P; Cools P; Van der Stighelen Y
    Acta Chir Belg; 2004 Aug; 104(4):468-70. PubMed ID: 15469167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resolution of necrolytic migratory erythema with somatostatin analogue in a patient diagnosed with pancreatic glucagonoma.
    Saavedra C; Lamarca A; Hubner RA
    BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31401568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Etiology and pathogenesis of necrolytic migratory erythema: review of the literature.
    Tierney EP; Badger J
    MedGenMed; 2004 Sep; 6(3):4. PubMed ID: 15520626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.